*Refresh the page if the below document does not appear.
Dr. Reddy’s Laboratories on Tuesday mentioned that an anti-trust lawsuit has been filed against them along with some other generic pharma companies including Celgene and Bristol Myers Squibb in the US on November 18, 2022.
The company stated that earlier this month Blenrep failed to meet the main goal of a study designed to show it was better than an existing treatment on the market. Thus, the company decided to stop the sale of Blenrep in the US amidst the fear that regulatory approval could be removed by the US FDA.
According to GlobalData, a leading data and analytics company, with a favorable route of administration LUM-201 has the potential to improve low rates of treatment compliance in PGHD (Pediatric Growth Hormone Deficiency) cases.
CPhI & P-MEC India, Informa Markets is organizing its event (15th edition) in an hybrid format from 29th November to 1st December, 2022 at the India Expo Centre, Greater Noida, Delhi – NCR.
The drugmaker Jazz Pharmaceuticals received FDA approval for a revised dosing schedule for its Blood Cancer Therapy ‘Rylaze’ , giving medical practitioners the option of prescribing intramuscular doses of the drug on Monday, Wednesday, and Friday.
The Haryana Government has started app-based monitoring to keep a check on the abuse of habit-forming drugs in the state. The app “SAATHI” has been launched as a pilot project in the Sonipat district.
USV Pharma is planning to expand its
pharma unit capacity at HPSIDC Industrial
Area, Baddi, in Himachal Pradesh’s Solan
district. The ₹ 97 crore project will cover
additional 3.39 acres of land and will employ
around 30 additional employees.
If you don’t already have an account click the button below to create your account.Create New Account